Company intelligence / Profile preview

ART Advanced Research Technologies

Montreal, Quebec, Canadakpmg.com ↗

Ownership: Private
Development stage: Commercial

Overview

ART Advanced Research Technologies was a Canadian medical device company specializing in advanced optical molecular imaging systems. Their flagship products included the Optix® preclinical imager and the SoftScan system for functional breast lesion assessment. The company collaborated with leading institutions such as Stanford University to validate its technologies. As of February 2013, the company filed for bankruptcy and ceased operations.

Therapeutic areas: Oncology
Modalities: DeviceOptical imaging device
Industry: Medical Imaging

Partnerships

GE Healthcare

Beyond the preview

Go deeper on ART Advanced Research Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ART Advanced Research Technologies.

Explore the full profile